SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries - Quaterly Results

19 Jan 2024 Evaluate
A fair growth of 17.62% in the revenue at Rs. 768.33 millions was reported in the December 2023 quarter as compared to Rs. 653.24 millions during year-ago period.The Company has registered profit of Rs. 107.72  millions for the quarter ended December 2023, a growth of 15.54%  over Rs. 93.23 millions millions achieved in the corresponding quarter of last year.The company reported a good operating profit of 174.96 millions compared to 147.24 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 768.33 653.24 17.62 2338.44 2142.43 9.15 2903.24 2494.05 16.41
Other Income 16.84 12.89 30.64 44.08 51.22 -13.94 66.72 26.30 153.69
PBIDT 174.96 147.24 18.83 487.29 469.32 3.83 624.85 530.25 17.84
Interest 16.72 12.03 38.99 45.94 28.75 59.79 42.87 11.55 271.17
PBDT 158.24 135.21 17.03 441.35 440.57 0.18 581.98 518.70 12.20
Depreciation 20.62 17.77 16.04 59.86 46.47 28.81 66.21 29.05 127.92
PBT 137.62 117.44 17.18 381.49 394.10 -3.20 515.77 489.65 5.33
TAX 29.90 24.21 23.50 88.63 72.82 21.71 100.18 109.37 -8.40
Deferred Tax 3.42 0.80 327.50 15.48 -8.12 -290.64 -2.06 10.53 -119.56
PAT 107.72 93.23 15.54 292.86 321.28 -8.85 415.59 380.28 9.29
Equity 323.48 307.43 5.22 323.48 307.43 5.22 307.43 307.43 0.00
PBIDTM(%) 22.77 22.54 1.03 20.84 21.91 -4.87 21.52 21.26 1.23

Sigachi Industries Share Price

22.60 -0.75 (-3.21%)
20-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1226.10
Cipla 1228.55
Zydus Lifesciences 935.00
Lupin 2326.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×